Ideaya Biosciences ( ($IDYA) ) has released its Q4 earnings. Here is a breakdown of the information Ideaya Biosciences presented to its investors.

SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company with a market capitalization of $4.5 million, announced nonclinical results for its ...

Reports Q1 revenue $88.71M ... CEO and co-founder of Twist Bioscience (TWST). Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They ...

Neurological therapeutics specialist Neurocrine Biosciences (NASDAQ:NBIX) reported mixed fourth-quarter earnings on Thursday, Feb. 6. Despite a slight miss on revenue expectations, its adjusted ...

Before you invest in Twist Bioscience Corporation (TWST), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

State of Alaska Department of Revenue lifted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 26.3% during the 4th quarter, according to its most recent disclosure with ...

the estimate revisions trend for Twist Bioscience: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current ...